JPS5657716A - Pharmaceutical composition derived from fomes japonicus - Google Patents
Pharmaceutical composition derived from fomes japonicusInfo
- Publication number
- JPS5657716A JPS5657716A JP13372979A JP13372979A JPS5657716A JP S5657716 A JPS5657716 A JP S5657716A JP 13372979 A JP13372979 A JP 13372979A JP 13372979 A JP13372979 A JP 13372979A JP S5657716 A JPS5657716 A JP S5657716A
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- detected
- fomes japonicus
- peaks
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
NEW MATERIAL:To effective component extracted Fomes japonicus. Peaks of IR absorption spectrum, about 3450, 2970, 1460, 1390, and 1040cm-1; peak of UV absorption spectrum, about 257W258nm; no characteristic absorption peak within the visible range in aqueous solution; color reactions, positive to Fehling's reagent and phenol-sulfuric acid reagent, false positive to phenylhydrazine reagent, ferric chloride reagent, etc.; low molecular weight free saccharides and amino acids, scarcely detected by thin layer chromatography; constituent elements, at least C, H and N are detected by elemental analysis; constituent saccharides, fucose, fructose and glucose; solubility, slightly soluble in hot water, very slightly soluble in water and methanol at room temperature; six peaks are detected by thermal decomposition gas chromatography.
USE: Composition for remedying and improving psychosomatic diseases.
PROCESS: The agent is prepared by extracting Fomes japonicus with hot water, removing the insoluble components from the extract, concentrating the extract at a low temperature (≤50°C), and subjecting the concentrate to dialysis and centrifugal separation.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13372979A JPS5657716A (en) | 1979-10-16 | 1979-10-16 | Pharmaceutical composition derived from fomes japonicus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13372979A JPS5657716A (en) | 1979-10-16 | 1979-10-16 | Pharmaceutical composition derived from fomes japonicus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5657716A true JPS5657716A (en) | 1981-05-20 |
Family
ID=15111539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13372979A Pending JPS5657716A (en) | 1979-10-16 | 1979-10-16 | Pharmaceutical composition derived from fomes japonicus |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5657716A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6783771B2 (en) | 2000-01-12 | 2004-08-31 | Life Science Laboratories Co., Ltd. | Physiologically active substance EEM-S originating in mushrooms, process for producing the same and drugs |
| JP2004307425A (en) * | 2003-04-10 | 2004-11-04 | Nonogawa Shoji Kk | Antistress agent |
-
1979
- 1979-10-16 JP JP13372979A patent/JPS5657716A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6783771B2 (en) | 2000-01-12 | 2004-08-31 | Life Science Laboratories Co., Ltd. | Physiologically active substance EEM-S originating in mushrooms, process for producing the same and drugs |
| JP4728551B2 (en) * | 2000-01-12 | 2011-07-20 | 有限会社生命科学研究所 | Physiologically active substance EEM-S from persimmon, its production method and medicine |
| JP2004307425A (en) * | 2003-04-10 | 2004-11-04 | Nonogawa Shoji Kk | Antistress agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5628202A (en) | Polysaccharide rbs substance, its preparation, and antitumor agent containing it as effective component | |
| Patil et al. | Non-random association of human acrocentric chromosomes | |
| JPS5657716A (en) | Pharmaceutical composition derived from fomes japonicus | |
| Yosizawa | Fractional estimation of glucosamine and galactosamine by paper chromatography. Third report | |
| JPS5657801A (en) | Ganoderma lucidum karst component and its preparation | |
| Allsobrook et al. | Sulphated polysaccharides of the Grateloupiaceae family Part V1. A polysaccharide from Aeodes ulvoidea | |
| JPS5466604A (en) | Polysaccharide m-30-c | |
| JPS56120621A (en) | Preparation of substance having wound remedying action | |
| JPS57112331A (en) | Medical composition of ganoderma lucidum component | |
| JPS5695901A (en) | Preparation of carrageenan by gelation with aqueous salt solution | |
| Soldati | Toxicological studies on ginseng | |
| JPS55149205A (en) | Agent for accelerating color development and increasing saccharide in citrus fruits | |
| JPS5533456A (en) | Separation of ginseng saponin | |
| JPS54105221A (en) | Preparation of stable concentrated dopa injection | |
| JPS57200321A (en) | Treatment of peppermint oil subjected to menthol-removal treatment | |
| JPS56127317A (en) | Preparation of carcinostatic substance | |
| JPS57165400A (en) | Saponin of astragali radix and its separation | |
| JPS5661993A (en) | Preparation of immune adjusting substance having antitumor action from mycelium belonging to genus peziza vesiculosa | |
| JPS57128631A (en) | Novel physiologically active substance | |
| JPS5527101A (en) | Preventive and remedy for infectious diseases | |
| JPS5441315A (en) | Anti-tumor substance and its preparation | |
| JPS5497692A (en) | Linear mannan | |
| JPS57139091A (en) | Carcinostatic substance tv-130, its preparation and carcinostatic agent containing the same | |
| JPS57171923A (en) | Melia azadirachta extract with activity of resisting malignant neoplasm | |
| JPS57174053A (en) | Preparation of soup stock from dried fish such as dried bonito |